The persistence of BRAF mutations throughout thyroid cancer development and the acquisition of additional mutations in ATC indicate a stepwise accumulation of mutations, which holds out the hypothesis of tumor progression from preexisting well-differentiated thyroid cancer to ATC (1, 11, 59). The gene discussed is BRAF; the disease is thyroid cancer.